Cooled vs Conventional RFA for Chronic Lower Back Pain
(Lumbar CvS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to compare two types of radiofrequency treatments for managing chronic low back pain originating in the lumbar facet joints. The study will test a cooled radiofrequency probe (COOLIEF* Cooled Radiofrequency Probe) against a standard one to determine which more effectively reduces pain. It suits individuals who have experienced non-radiating low back pain for at least three months and have not found relief from treatments like exercise and pain relievers. Participants should also have experienced significant pain relief from specific diagnostic tests. As an unphased trial, this study provides an opportunity to explore innovative treatment options for chronic low back pain.
Do I need to stop taking my current medications for the trial?
You may need to keep your current pain medications stable, as the trial requires that analgesics like Neurontin (gabapentin) and Cymbalta (duloxetine) remain at a stable dosage for at least 6 weeks before the trial and not change during the study without approval.
What prior data suggests that these radiofrequency probes are safe for treating chronic axial low back pain?
Research has shown that the COOLIEF Cooled Radiofrequency Probe is generally well-tolerated by patients. Studies have found it effectively reduces pain in individuals with long-term back pain from lumbar facet joints. Although these studies don't list specific side effects, the treatment is considered minimally invasive, typically resulting in fewer side effects.
Research also supports the safety and effectiveness of the Standard Radiofrequency Probe. Like the cooled version, it targets nerves in the lower back to help reduce pain. Various studies have tested both treatments, confirming their general safety for patients. However, as with any medical treatment, individual experiences may differ, so discussing any concerns with a healthcare provider is important.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer a new way to tackle chronic facetogenic low back pain by using radiofrequency energy to target medial branch nerves. The COOLIEF* Cooled Radiofrequency Probe is unique because it uses cooled radiofrequency energy, which may provide longer-lasting pain relief compared to heat alone, potentially offering a more effective and sustained option for patients. Unlike conventional radiofrequency treatments that use heat to reduce nerve pain, the cooled approach can treat a larger area with reduced risk of overheating tissues. This innovative method could mean more significant pain reduction and improved quality of life for patients struggling with chronic back pain.
What evidence suggests that this trial's treatments could be effective for chronic axial low back pain?
Research has shown that the COOLIEF Cooled Radiofrequency Probe, a treatment in this trial, can reduce pain for many with long-term lower back pain. One study found that 85.92% of patients experienced improved pain levels after treatment, with 14.08% achieving complete pain relief. COOLIEF has also been proven to relieve pain for up to 24 months, enhance physical movement, and reduce the need for pain medications. This trial will compare the effectiveness of COOLIEF with the Standard Radiofrequency Probe, another treatment option being tested for lower back pain due to issues in the lumbar facet joints.12678
Who Is on the Research Team?
David Provenzano
Principal Investigator
Pain Diagnostics and Interventional Care
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either Cooled Radiofrequency Ablation (CRFA) or Conventional Radiofrequency Ablation (SRFA) to manage chronic facetogenic low back pain
Follow-up
Participants are monitored for safety and effectiveness after treatment, with primary endpoint at 6 months and continued monitoring up to 12 months
What Are the Treatments Tested in This Trial?
Interventions
- COOLIEF* Cooled Radiofrequency Probe
- Standard Radiofrequency Probe
Find a Clinic Near You
Who Is Running the Clinical Trial?
Avanos Medical
Lead Sponsor